Skip to content
  • News
  • Contact us
  • Careers
  •  
    • Kedrion Corporate
    • Kedrion S.P.A
    • Kedrion Biopharma GmbH
    • Kedrion Biopharma – Austria
    • Kedrion Biopharma – Portugal
    • Kedrion Biopharma – Poland
    • Kedrion Biopharma – Switzerland
    • Kedrion Biopharma – Russia
    • HUMAN Bioplazma Kft
    • Kedrion Mexicana S.A.
    • Kedrion de Colombia
    • Kedrion Betaphar
    • KEDPLASMA USA
    • Bio Products Laboratory Limited
    • RhoGAM
    • Koate
    • Gammaked
    • Albuked
    • KEDRAB
  •  
  •   
    • Linkedin
  • About us
    • Corporate Structure
    • Annual Report
    • Corporate Social Responsibility
      • Environment, Health & Safety
      • Supporting our people
      • Support to communities
  • Expertise
    • Activities
    • Medical & Scientific Information
    • Product Development
    • Quality & Safety
  • Therapies
  • Services
    • Italian partnership
    • Contract manufacturing
    • Technology transfer
    • Biological Safety Center
  • Donors
    • Plasma
  • Pharmacovigilance
Find in Kedrion

NEWS


  • CORPORATE
  • EVENTS

Kedrion-Kamada collaboration, first batch of Covid-19 IG released in Israel

Jun 21, 2020 | CORPORATE

The two companies are now working to expand the Clinical Development Program to the US

Coronavirus, from plasma an anti Covid-19 treatment

Apr 06, 2020 | CORPORATE

In order to tackle the serious health emergency caused by the COVID-19 pandemic, Kedrion ‘s R&D department set to work immediately to develop potential therapies in the shortest possible time. In this respect, our efforts are concentrated on the use of “convalescent plasma” donated by patients who have recovered from the disease.  The plasma, rich in anti-virus antibodies, undergoes pathogen

Kedrion Statement on the novel Coronavirus

Mar 19, 2020 | CORPORATE

In accordance with international, national and local authority guidelines, Kedrion has acted immediately in dealing with the epidemiological emergency linked to the spread of the novel Coronavirus, and has taken all necessary measures to safeguard the health and safety of its employees and guarantee the continuation of business activities. Paolo Marcucci, Chairman & CEO has stated:

SIMEST ENTERS KEDRION BIOPHARMA INC. SHARE CAPITAL

Feb 24, 2020 | CORPORATE

Milan, 24th  February 2020 – Società Italiana per le Imprese all’Estero – SIMEST S.p.A. (SIMEST) has today become a minority shareholder of Kedrion Biopharma Inc. (Kedrion Biopharma) with a stake of 4.5% by means of payment of a capital increase of Kedrion Biopharma of USD equivalent of Euro 10 million. Kedrion S.p.A. (Kedrion) will hold the

Kedrion Biopharma Announces Completion of Enrollment for CARES10

Feb 17, 2020 | CORPORATE

A Phase 3, Multi-Center Study to Assess a 10% Ig in Adults with Primary Immunodeficiency Disease

Anti-D 50th Anniversary Celebration Held on Nov. 1, 2018:

Nov 05, 2018 | CORPORATE

1st Annual International Meeting for Global Eradication of Rh Disease

KEDRAB® (Rabies Immune Globulin [Human]) Now Shipping

May 09, 2018 | CORPORATE

Distribution Timed to Meet Spring/Summer Demand

Human Rabies – An Interview with Peter J. Costa MPH

Mar 26, 2018 |

Rabies Immune Globulin Brand Director at Kedrion Biopharma

Global Maternal Health Milestone Reached: 50th Anniversary

Feb 12, 2018 | CORPORATE

U.S. Approval of RhoGAM®, Rho(D) Immune Globulin

KEDRAB™: Pivotal Phase 2/3 Data presented at RITA Conference

Dec 13, 2017 | EVENTS

Kedrion Biopharma and Kamada Received FDA Approval of the Product in Q3 2017

Posts navigation

Previous 1 2 3 4 5 Next

Kedrion

Kedrion Biopharma Inc.
All rights reserved.
Dec 2019 CO-0109-11-2019
INTENDED FOR US AUDIENCES ONLY

INFORMATION

  • Privacy Statement
  • Terms of Use
  • Site map

HIGHLIGHTS

  • Annual Declaration of Compliance for the State of California
  • Healthcare Compliance Program Summary
  • Code of Ethics and Code of Conduct

Where We Are

© 2023 Kedrion Biopharma Inc.

You are now leaving www.kedrion.us Medical information including licensed uses may be different outside of USA. Are you sure?

Kedrion usLogo Header Menu
    • About us
      • Corporate Structure
      • Annual Report
      • Corporate Social Responsibility
        • Environment, Health & Safety
        • Supporting our people
        • Support to communities
    • Expertise
      • Activities
      • Medical & Scientific Information
      • Product Development
      • Quality & Safety
    • Therapies
    • Services
      • Italian partnership
      • Contract manufacturing
      • Technology transfer
      • Biological Safety Center
    • Donors
      • Plasma
    • Pharmacovigilance
  • News
  • Contact Us
  • Careers
  • Kedrion’s Sites
    • Kedrion Corporate
    • Kedrion S.p.A
    • Kedrion Biopharma GmbH
    • Kedrion Biopharma – Austria
    • Kedrion Biopharma – Portugal
    • Kedrion Biopharma – Poland
    • Kedrion Biopharma – Switzerland
    • Kedrion Biopharma – Russia
    • HUMAN Bioplazma Kft
    • Kedrion Mexicana S.A.
    • Kedrion Betaphar
    • KEDPLASMA USA
    • RhoGAM
    • Koate
    • Gammaked
    • Albuked
    • KEDRAB
  • Social Network
    • Linkedin